[HTML][HTML] Tnfrsf4-expressing regulatory T cells promote immune escape of chronic myeloid leukemia stem cells
M Hinterbrandner, V Rubino, C Stoll, S Forster… - JCI insight, 2021 - ncbi.nlm.nih.gov
Leukemia stem cells (LSCs) promote the disease and seem resistant to therapy and immune
control. Why LSCs are selectively resistant against elimination by CD8+ cytotoxic T cells …
control. Why LSCs are selectively resistant against elimination by CD8+ cytotoxic T cells …
Enhanced dendritic cell immune activation by combined inhibition of nr2f6 with cannibidiol
T Ichim, D Koos - US Patent App. 17/035,955, 2021 - Google Patents
Cancer immunotherapy has developed into a new branch of oncology, offering substantial
benefit to patients with various stages of cancer, which previously had no treatment options …
benefit to patients with various stages of cancer, which previously had no treatment options …